XML 59 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory (Details) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Raw materials $ 32,630 $ 31,874
Work-in-process 122,971 54,455
Finished goods 22,384 34,630
Total inventory 177,985 120,959
Inventories - current 35,937 41,995 [1]
Inventories-noncurrent 142,048 $ 78,964 [1]
Inventory incurred prior to FDA approval $ 32,600  
Minimum    
Period of lower average per unit cost of materials 12 months  
Maximum    
Period of lower average per unit cost of materials 18 months  
[1] The condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated financial statements at that date.